US drugmaker Eli Lilly to cut insulin prices
US drugmaker Eli Lilly and Company announced that it was slashing prices of its most commonly-prescribed insulins by 70 percent. Lilly said it would cut the price of its non-branded insulin to.
US drugmaker Eli Lilly and Company announced that it was slashing prices of its most commonly-prescribed insulins by 70 percent. Lilly said it would cut the price of its non-branded insulin to.